[Source: Market Watch] – During an official visit of the Translational Genomics Research Institute (TGen) by H.R.H. Prince Guillaume, Hereditary Grand Duke of Luxembourg and Jeannot Krecke, Luxembourg’s Minister for the Economy & Foreign Trade, Life Technologies Corporation and the Integrated Biobank of Luxembourg (IBBL) today announced a strategic partnership aimed at advancing the field of personalized medicine and yielding greater insights into the genetic causes of disease.
The Integrated Biobank of Luxembourg (IBBL) is an independent, non-profit biobanking and biotechnology foundation designed to support investigators worldwide in a new era of research and the next generation of healthcare. With an initial focus on cancer, the IBBL collects, stores, analyzes, and distributes a wide variety of the highest quality biospecimen samples while ensuring the strictest confidentiality and protection of donors’ data. The IBBL has the technology and expertise to provide valuable genetic and molecular information in addition to medical records and environmental factors related to the donor.
For more information: Life Technologies and the Integrated Biobank of Luxembourg Form Strategic Partnership